All stock lists
Protagonist Therapeutics, Inc (NASDAQ:PTGX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
140.32+1.89 (+1.37%)
Insider Score
––Not scored
PTGX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PTGX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 213.47 M | 56.37 M | 7.44 M | 4.71 M | 5.55 M | 28.32 M |
| Revenue Growth (YoY) | 3749.17 % | 99.03 % | -95.64 % | 0.79 % | 33.09 % | -88.89 % |
| Cost of Revenue | 0.00 | 407.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 213.47 M | 55.96 M | 7.44 M | 4.71 M | 5.55 M | 28.32 M |
| SG&A Expense | 12.65 M | 13.28 M | 11.43 M | 11.13 M | 10.55 M | 11.74 M |
| R&D Expense | 42.06 M | 46.74 M | 46.36 M | 40.00 M | 37.04 M | 35.89 M |
| Operating Expenses | 54.71 M | 59.61 M | 57.79 M | 51.13 M | 47.59 M | 47.63 M |
| Operating Income | 158.77 M | -3.65 M | -50.35 M | -46.42 M | -42.04 M | -19.31 M |
| Pretax Income | 165.11 M | 2.28 M | -43.72 M | -39.34 M | -34.60 M | -11.65 M |
| Tax Provision | 2.27 M | -1.50 M | 666.00 K | 0.00 | 172.00 K | 0.00 |
| Net Income | 162.85 M | 3.78 M | -44.38 M | -39.34 M | -34.77 M | -11.65 M |
| EPS (Basic) | 2.47 | 0.06 | -0.69 | -0.62 | -0.55 | -0.19 |
| EPS (Diluted) | 2.29 | 0.05 | -0.69 | -0.62 | -0.55 | -0.19 |
| Shares Outstanding | 65.94 M | 65.09 M | 63.57 M | 63.77 M | 63.51 M | 62.96 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.